Females and ethnic minorities are underrepresented in the first and senior authorships positions of academic publications. This stems from various structural and systemic inequalities and discrimination in the journal peer-review process, as well as educational, institutional, and organizational cultures. A retrospective bibliometric study design was used to investigate the representation of gender and racial/ethnic groups in the authorship of critical care randomized controlled trials in 12 high-impact journals from 2000 to 2022. In the 1398 randomized controlled trials included in this study, only 24.61% of the first authors and 16.6% of the senior authors were female. Although female authorship increased during the study period, authorship was significantly higher for males throughout (Chi-square for trend, p < 0.0001). The educational attainment [χ2(4) = 99.2, p < 0.0001] and the country of the author's affiliated institution [χ2(42) = 70.3, p = 0.0029] were significantly associated with gender. Male authorship was significantly more prevalent in 10 out of 12 journals analyzed in this study [χ2(11) = 110.1, p < 0.0001]. The most common race/ethnic group in our study population was White (85.1% women, 85.4% males), followed by Asians (14.3% females, 14.3% males). Although there was a significant increase in the number of non-White authors between 2000 and 2022 [χ2(22) = 77.3, p < 0.0001], the trend was driven by an increase in non-White male and not non-White female authors. Race/ethnicity was significantly associated with the country of the author’s affiliated institution [χ2(41) = 1107, p < 0.0001] but not with gender or educational attainment. Persistent gender and racial disparities in high-impact medical and critical care journals underscore the need to revise policies and strategies to encourage greater diversity in critical care research.
Background: In recent years, innovation in healthcare technology has significantly improved the efficiency of the healthcare system. Advancements have led to better patient care and more cost-effective services. The electronic medical record (EMR) system, in particular, has enhanced interoperability and collaboration across healthcare departments by facilitating the exchange and utilization of patient data. The COVID-19 pandemic further accelerated this trend, leading to a surge in telemedicine services, which rely on electronic communication to deliver healthcare remotely. Main body: Integrating artificial intelligence (AI) and machine learning (ML) in healthcare have been instrumental in analyzing vast data sets, allowing for identifying patterns and trends that can improve care delivery and pinpoint potential issues. The proposal of a unified EMR system in the USA aims to capitalize on these technological advancements. Such a system would streamline the sharing of patient information among healthcare providers, improve the quality and efficiency of care, and minimize the likelihood of errors in patient treatment. Conclusion: A unified electronic medical record system represents a promising avenue for enhancing interoperability within the US healthcare sector. By creating a more connected and accessible network of patient information, it sets the stage for a transformation in healthcare delivery. This change is imperative for maintaining the momentum of progress in healthcare technology and realizing the full potential of recent advancements in patient care and system efficiency.
2 October 2024 in American Journal of Kidney Diseases
Introduction: Clinical practice guidelines recommend lower (35.0°C–35.5°C) instead of standard dialysate temperature (36.5°C–37.0°C) to mitigate the risk of intradialytic hypotension. However, many studies have been available since the recommendations were published. Hence, the current study aimed to provide an updated meta-analysis of clinical outcomes with cold versus standard dialysate. Methods: This systematic review and meta-analysis included eligible articles indexed in PubMed, Cochrane Library, Web of Science, and Scopus, evaluating the effects of cooled versus standard dialysate in hemodialysis patients. The primary outcomes were intradialytic hypotension, mean arterial pressure, thermal-related discomfort, and body temperature changes. A random-effects model was used for all outcomes due to high heterogeneity (I2: intradialytic hypotension = 60%, mean arterial pressure = 72%, symptoms of discomfort = 41%, decrease in body temperature = 87%). Sensitivity analysis was performed using the “leave-one-out” approach, and the Cochrane risk-of-bias tool was used to assess study quality. A total of 31 studies were included. Pooled results indicate that cooled dialysis was associated with a lower risk of intradialytic hypotension (RR 0.67; 95% CI: 0.48–0.93; p = 0.02) and higher mean arterial pressure (MD 7.18; 95% CI: 3.79–10.58; p < 0.01). However, cooled dialysis was associated with a higher risk of discomfort (RR 1.55; 95% CI: 1.25–1.93; p < 0.01) and a significant decrease in body temperature (MD −0.29; 95% CI: −0.52 to −0.05; p = 0.02). This systematic review and meta-analysis is registered in PROSPERO under ID CRD42024589307. Conclusions: Using cooled dialysate might be a simple approach to reduce interdialytic hypotension risk and increase mean arterial pressure, albeit at the cost of patient discomfort. The limitations associated with the quality of included studies underscore the need for high-quality, multicenter studies with large/diverse study populations.